接受连续性血液净化的PICU患者的临床亚表型与短期结局
亚表型I短期生存最佳、II最差、III居中,28天生存组间显著分离,ICU住院时间亦不同。探索性分析提示高容量血液滤过暴露与ICU转归的关联呈亚表型依赖。结论提示CBP启动时存在显著异质性,亚表型分层可能有助于风险刻画与试验富集,但需前瞻性验证。
要点
- CBP启动时用7变量(AST、血红蛋白、氧合指数、pSOFA-2、降钙素原、体重、pH)可将儿童分为3种可重复亚表型,交叉验证的监督模型判别力高。
- 亚表型I短期生存最佳、II最差、III居中,28天生存三组间显著分离,ICU住院时间亦不同。
- 探索性分析提示高容量血液滤过暴露与ICU转归的关联因亚表型而异,不能一概而论。
- 该分层为回顾性数据驱动,尚未前瞻性验证,不能直接作为床旁决策阈值。
适用人群与场景
- 排除人群原文未提及。
诊断标准与关键阈值
- 亚表型基于CBP启动时7变量签名无监督聚类:天冬氨酸氨基转移酶、血红蛋白、氧合指数、儿科 logistic 器官功能障碍-2评分、降钙素原、体重、pH。
- 原文未给出各变量的具体界值或评分阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- CBP启动时用7变量无监督聚类识别出3种可重复亚表型,呈现不同多维生理谱而非单纯严重度梯度。
- 亚表型I短期生存最佳,II最差,III居中,28天生存组间显著分离;亚表型间ICU住院时间亦不同。
- 探索性分析提示高容量血液滤过暴露与ICU转归的关联呈亚表型依赖。
- 交叉验证的监督模型对亚表型判别力高。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:回顾性设计、数据驱动亚表型、高容量血液滤过关联为探索性分析、结论需前瞻性验证。
对床旁实践的改变
- 提示CBP启动时儿童存在显著临床异质性,单一严重度评估不足以刻画预后,可考虑亚表型思路用于风险分层与试验富集。
- 高容量血液滤过与ICU转归的关联因亚表型而异,床旁不应将某一亚表型的探索性关联外推至所有CBP儿童。
- 亚表型尚未前瞻性验证,不能作为床旁决策阈值或改变CBP启动/停止指征。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To characterize clinical heterogeneity among PICU patients receiving continuous blood purification (CBP) and identify data-driven subphenotypes associated with distinct short-term outcomes.
DESIGN: Multicenter, retrospective cohort study.
SETTING: Fifteen PICUs (from January 2019 to August 2024).
PATIENTS: Children (1 mo to 18 yr) receiving CBP during PICU hospitalization.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: In this multicenter cohort of 598 CBP-treated children, unsupervised clustering at CBP initiation identified three reproducible subphenotypes using a seven-variable signature comprising aspartate aminotransferase, hemoglobin, oxygenation index, Pediatric Logistic Organ Dysfunction-2 score, procalcitonin, weight, and pH. These subphenotypes showed distinct multidomain physiologic profiles rather than a simple severity gradient. Subphenotype I had the most favorable short-term survival profile, subphenotype II had the poorest survival, and subphenotype III showed an intermediate pattern, with significant separation in 28-day survival across groups. Subphenotypes also differed in ICU length of stay, and exploratory analyses suggested subphenotype-dependent associations between high-volume hemofiltration exposure and ICU discharge. Cross-validated supervised models showed high discriminability of subphenotype assignment.
CONCLUSIONS: CBP-treated children exhibited distinct subphenotypes at CBP initiation with divergent short-term prognoses, highlighting marked heterogeneity at this treatment stage. Subphenotype-based stratification may support risk characterization and trial enrichment and facilitate hypothesis generation regarding heterogeneity of treatment associations. Prospective validation is warranted.
参考来源
- Huang K, Ke J, Wang Z, et al. Clinical Subphenotypes and Short-Term Outcomes in PICU Patients Receiving Continuous Blood Purification. Crit Care Explor. 2026. PMID: 42608963. doi:10.1097/CCE.0000000000001460
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。